MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0011092
Rmanirex Pharma Private Limited
Rmanirex Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹36.41 Lakh
▼ 18% YoY
Net loss · FY 2025
₹29,551
Net margin -0.8%
EBITDA · FY 2025
₹1.64 Lakh
EBITDA margin 4.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹13.87 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Rmanirex Pharma Private Limited
Data last updated:
Rmanirex Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2020PTC142591. Its GSTIN is 36AAKCR3333C1ZM (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Maniraju Ravulapalli and Konduru Sandhya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 – 8 – 720/1/3 Part Portion Of First Floor Room No 3 Near Axis Bank Vidyanagar, Hyderabad, Telangana, India – 500044.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.41 Lakh, a decline of 18% compared to the previous year. For the same year it recorded a net loss of ₹29,551 (net margin -0.8%) and EBITDA of ₹1.64 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years.
As per MCA filings, the company has open charges of ₹13.87 Lakh on record.
Rmanirex Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0011092).
Company details
CIN U51909TG2020PTC142591
Registration Number 142591
Incorporation Date 07 August 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0011092
Recognitions & Rankings of Rmanirex Pharma
Contact details
Rmanirex Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1 – 8 – 720/1/3 Part Portion Of First Floor Room No 3 Near Axis Bank Vidyanagar, Hyderabad, Telangana, India – 500044
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rmanirex Pharma Private Limited, buy the company report.
Comprehensive company report
Rmanirex Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Rmanirex Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rmanirex Pharma Private Limited, buy the company report.
Financials of Rmanirex Pharma Private Limited
FY 2025 filings availableRmanirex Pharma Private Limited reported revenue of ₹36.41 Lakh (down 18% YoY) for FY 2025.
Revenue · FY 2025
₹36.41 Lakh ▼ 18%
Net loss · FY 2025
₹29,551 margin -0.8%
EBITDA · FY 2025
₹1.64 Lakh margin 4.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 18%
3 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 40%
3 years · compounded
▲ 22%
Revenue fell 18% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.64 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹29,551 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | -0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rmanirex Pharma Private Limited, buy the company report.
Board of directors of Rmanirex Pharma Private Limited
Rmanirex Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Konduru Sandhya | Additional Director | 14 Jan 2021 | 5 Years 10 Months | Current |
| Maniraju Ravulapalli | Director | 07 Aug 2020 | 6 Years 3 Months | Current |
Peer comparison
Rmanirex Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lumos Drugs & Surgical Private Limited | ₹36.56 Lakh (FY 2025) | 137.0% | Guwahati, Assam, India | |||
| Maars Formulations Private Limited | ₹36.53 Lakh (FY 2025) | 15.0% | New Delhi, Delhi, India | |||
| Zdravi Duvera India Limited | ₹36.53 Lakh (FY 2018) | -42.0% | Navi Mumbai, Maharashtra, India | |||
| Rmanirex Pharma Private Limitedthis company | ₹36.41 Lakh (FY 2025) | -₹29,551 | -0.8% | -18.0% | Hyderabad, Telangana, India | |
| Andhra Agro-Vet Associates Private Limited | ₹36.4 Lakh (FY 2025) | -84.0% | Hyderabad, Telangana, India | |||
| Ads Lifescience Private Limited | ₹36.37 Lakh (FY 2025) | 17.0% | Patna, Bihar, India |
To see the full peer comparison of Rmanirex Pharma Private Limited, buy the company report.
Auditor
Rmanirex Pharma Private Limited is audited by YOGANANDA & SIVAKANTH for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| YOGANANDA & SIVAKANTH | FY 2022 | 018334S |
Shareholding
The shareholding of Rmanirex Pharma Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Rmanirex Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹13.87 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Jun 2025 | 101141197 | Hdfc Bank Limited | ₹7.3 Lakh | Open | |
| 10 Oct 2022 | 100678552 | Hdfc Bank Limited | ₹6.57 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Rmanirex Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rmanirex Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rmanirex Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAKCR3333C1ZM | Telangana | Active | 07 Sep 2020 |
To see the full GST registrations and return filing status of Rmanirex Pharma Private Limited, buy the company report.
Recent activity
Rmanirex Pharma Private Limited has 5 board changes on record since 2020: 2 appointments and 3 cessations. The latest: Ramya Polina ceased to be Additional Director on 01 Dec 2023.
AGM
Rmanirex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.30 Lakh with Charge ID 101141197 was registered on 02 Jun 2025.
Filing
Rmanirex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Ramya Polina ceased to be Additional Director.
Ceased
Tejaswini Putti ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 6.57 Lakh with Charge ID 100678552 was registered on 10 Oct 2022.
Ceased
Konduru Subbarama Raju ceased to be Director.
Appointed
Konduru Sandhya was appointed as Additional Director.
Appointed
Maniraju Ravulapalli was appointed as Director.
Incorporation
07 Aug 2020
Rmanirex Pharma Private Limited was registered on 07 Aug 2020 with Roc Hyderabad & aged 6 years 3 months as per MCA records.
Frequently asked questions
Rmanirex Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 August 2020 (6+ years old) and is registered under CIN U51909TG2020PTC142591.
Rmanirex Pharma has 2 current directors:
- Konduru Sandhya - Additional Director
- Maniraju Ravulapalli - Director
The latest financial statements of Rmanirex Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Rmanirex Pharma is 36AAKCR3333C1ZM, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Rmanirex Pharma is U51909TG2020PTC142591. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rmanirex Pharma was incorporated on 07 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Rmanirex Pharma by revenue are Lumos Drugs & Surgical Private Limited, Maars Formulations Private Limited, Zdravi Duvera India Limited, Andhra Agro-Vet Associates Private Limited, Ads Lifescience Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ramya Polina ceased to be Additional Director on 01 Dec 2023. Tejaswini Putti ceased to be Additional Director on 01 Dec 2023. Konduru Subbarama Raju ceased to be Director on 10 Sep 2022. Rmanirex Pharma has 5 board changes on record in total.
Yes, Rmanirex Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0011092).
The registered office of Rmanirex Pharma is at 1 – 8 – 72013 Part Portion Of First Floor Room No 3 Near Axis Bank Vidyanagar, Hyderabad, Telangana, India – 500044.
Rmanirex Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages